Springer Upper Tract Urothelial Carcinoma

Upper Tract Urothelial Carcinoma represents the first book of its kind to be dedicated solely to UTUC. It's aim is to improve understanding and eventually care of a disease that is greatly understudied and underappreciated, yet commonly dealt with by many medical and urologic oncologists. The volume features new data regarding genetic susceptibility, gene expression studies and causative factors; contemporary concepts and controversies regarding diagnosis and staging of UTUC; prediction tools and their value in treatment decisions within each disease stage and patient selection and treatment options such as endoscopic management, distal ureterectomy, radical nephroureterectomy and chemotherapy. Up-to-date information regarding boundaries of surgical resection, indication and extent of lymphadenectomy is covered as well as the role of perioperative/neoadjuvant chemotherapy in patients with high-risk UTUC. Upper Tract Urothelial Carcinoma will be of great value to all Urologists, Medical Oncologists and fellows in Urologic Oncology as well as upper level residents in training in Urology and Medical Oncology. Review From the book reviews:“The purpose is to create the first baseline and comprehensive book on UTUC. … Anyone with an interest or even relatively superficial contact with a patient with UTUC should find this book of interest. Residents and fellows in urology and oncology will find it valuable. … This book will have a definite role as the initial comprehensive treatise on UTUC.” (Demetrius H. Bagley, Doody’s Book Reviews, January, 2015) From the Back Cover Upper Tract Urothelial Carcinoma represents the first book of its kind to be dedicated solely to UTUC. Its aim is to improve understanding and eventually care of a disease that is greatly understudied and underappreciated, yet commonly dealt with by many medical and urologic oncologists. The volume features new data regarding genetic susceptibility, gene expression studies and causative factors; contemporary concepts and controversies regarding diagnosis and staging of UTUC; prediction tools and their value in treatment decisions within each disease stage andpatient selection and treatment options such as endoscopic management, distal ureterectomy, radical nephroureterectomy and chemotherapy. Up-to-date information regarding boundaries of surgical resection, indication and extent of lymphadenectomy are covered as well as the role of perioperative/neoadjuvant chemotherapy in patients with high-risk UTUC.   Upper Tract Urothelial Carcinoma will be of great value to all Urologists, Medical Oncologists, and fellows in Urologic Oncology as well as upper level residents in training in Urology and Medical Oncology. About the Author Shahrokh F. Shariat, M.D. Professor and Chairman Department of Urology and Comprehensive Cancer Center Medical University of Vienna, Vienna General HospitalWähringer Gürtel 18-20, A-1090 Vienna, Austria Evanguelos Xylinas, MD Department of Urology Cochin Hospital, Paris Descartes University 27 rue du Faubourg Saint Jacques Paris, 75014, France